K-State licenses technology for coronavirus, norovirus compoundsMarch 2, 2020As global concerns surrounding the novel coronavirus COVID-19 continue to escalate, Kansas State University (K-State) has licensed a technology it says might lead to the production of an antiviral drug treatment.
SPONSORED CONTENTSupport patients' cognitive function and mobility.Cognitive and mobility decline are common issues facing aging pets, and new Hill's Prescription Diet Brain Care + j/d can help. + Learn More